Biotech Values

[drbio45]

Glad I was buying indevus (idev) when the news about the partnership came out and the stock didn't go up

that was an inefficency in the market.

Other inefficiencies are genr avn gene fmti and neop. There are others but there is no sense naming them all

I sold the last of my cjc. The technology is great, but I think there will be some weakness until the next data set comes out in July

I am not as sure about my sales as my buys.

When I buy something, I think it has to be really cheap.